Merck KGaA (ETR:MRK)
Germany flag Germany · Delayed Price · Currency is EUR
112.85
-0.20 (-0.18%)
Jul 29, 2025, 5:38 PM CET

Merck KGaA Company Description

Merck KGaA operates as a science and technology company in Germany.

It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.

Its Healthcare segment discovers, develops, manufacturers, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, endocrinology, as well as cardiovascular, diabetes, thyroid disorders, and multiple sclerosis; general medicines; and injection device and disease monitoring software.

The Electronics segment supplies materials for the semiconductor and display industries and surface design, such as delivery systems and services, as well as surface solutions, including cosmetics, effect pigments, and functional solutions.

In addition, it has in-licensing agreement with Debiopharm International SA for developing and commercializing drug candidates for the treatment of head and neck cancer; Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer; and Abbisko Therapeutics Co. Ltd. for developing and commercializing of drug candidates for the treatment of tenosynovial giant cell tumor, as well as license and collaboration agreement with Merck KGaA to discover two targeted protein degraders against critical oncogenic proteins.

The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E.

Merck KG.

Merck KGaA
Merck KGaA logo
CountryGermany
Founded1668
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees59,020
CEOBelen Garijo Lopez

Contact Details

Address:
Frankfurter Strasse 250
Darmstadt, 64293
Germany
Phone49 6151 72 0
Websitemerckgroup.com

Stock Details

Ticker SymbolMRK
ExchangeDeutsche Börse Xetra
Fiscal YearJanuary - December
Reporting CurrencyEUR
ISIN NumberDE0006599905
SIC Code2834

Key Executives

NamePosition
Jean Charles WirthMember of the Executive Board and Chief Executive Officer Life Science
Danny Bar-Zohar M.D.Member of the Executive Board and Chief Executive Officer of Healthcare
Dr. Kai BeckmannChief Executive Officer of Electronics and Member of the Executive Board
Belen Garijo Lopez M.D.Chair of Executive Board and Chief Executive Officer
Helene von RoederChief Financial Officer and Member of Executive Board
Khadija Ben HammadaMember of the Executive Board and Chief People Officer
Florian SchraederHead of Investor Relations
Frank GotthardtHead of Corporate and Government Relations - Europe
Marc HornHead of Life Science Controlling
Dr. Michael HeckmeierHead of the Display Materials Business Unit for Performance Materials